Accolade, Inc. signed a definitive agreement to acquire Innovation Specialists, LLC (d/b/a 2nd.MD) for $460 million. 2nd.MD provides medical decision support services for consumers. Accolade intends to integrate 2nd.MD’s services with Accolade’s health and benefits solutions and clinical service offerings. Accolade will continue to offer 2nd.MD’s service on a stand-alone basis as well.

The purchase price of up to $460 million will consist of $230 million in cash, $130 million in Accolade common stock, and up to $100 million of Accolade common stock payable upon the achievement of defined revenue . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

Merger & Acquisitions

Submit a Bulletin
  • This field is for validation purposes and should be left unchanged.
  • Max. file size: 98 MB.